Catalent, a prominent contract development and manufacturing organization (CDMO), has announced the divestment of its Somerset, New Jersey, oral solids development and small-scale manufacturing facility to Ardena, a Belgian CDMO. This transaction marks Ardena's entry into the U.S. market and
The pharmaceutical packaging industry stands at the precipice of a significant transformation. With an anticipated growth from $110.55 billion in 2024 to $176.94 billion by 2032, driven by the increasing prevalence of biologics, stringent regulations, and the menace of drug counterfeiting, it is
The biotechnology industry is currently experiencing a wave of renewed interest, particularly in the field of immunology. A shining example of this trend is Upstream Bio, a Massachusetts-based firm that recently made headlines with its $255 million initial public offering (IPO). The substantial
The recent reaffirmation of Piper Sandler's Overweight rating for Sutro Biopharma (NASDAQ: STRO) has sparked investor interest. While the company's shares have experienced significant volatility, the solid clinical advancements and strategic partnerships suggest potential growth. Analyzing Sutro’s
The biopharmaceutical sector has witnessed a significant surge in investor enthusiasm, and CAMP4 Therapeutics is a testament to this renewed interest. The Cambridge, Massachusetts-based biotech firm has successfully raised $75 million through its initial public offering (IPO), marking it as one of
The realm of biotechnology and digital health is increasingly characterized by burgeoning partnerships between pharmaceutical giants and innovative start-ups. These alliances are more than just trendy business moves; they represent a technological and strategic pivot aimed at advancing research,
